391P Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in patients with pancreatic and biliary tract cancerJ.A. Bridgewater, Juan W. Valle, R. Gillmore et al.|Annals of Oncology|2024Cited by 2